Treatment of cutaneous leishmaniasis with sodium stibogluconate and allopurinol in a routine setting in Ethiopia: clinical and patient-reported outcomes and operational challenges

Saskia van Henten, Fentaw Bialfew, Seid Hassen, Feleke Tilahun, Johan van Griensven, Seid Getahun Abdela
doi: https://doi.org/10.1101/2023.07.05.23292210

Article Information

doi 
https://doi.org/10.1101/2023.07.05.23292210
History 
  • July 6, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.

Author Information

  1. Saskia van Henten1,*,
  2. Fentaw Bialfew2,
  3. Seid Hassen2,
  4. Feleke Tilahun2,
  5. Johan van Griensven1 and
  6. Seid Getahun Abdela3
  1. 1Institute of Tropical Medicine, Antwerp, Belgium
  2. 2Boru Meda Hospital, Dessie, Ethiopia
  3. 3Wollo University, Dessie, Ethiopia
  1. ↵*Corresponding author; email: svanhenten{at}itg.be
Back to top
Posted July 06, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Treatment of cutaneous leishmaniasis with sodium stibogluconate and allopurinol in a routine setting in Ethiopia: clinical and patient-reported outcomes and operational challenges
Saskia van Henten, Fentaw Bialfew, Seid Hassen, Feleke Tilahun, Johan van Griensven, Seid Getahun Abdela
medRxiv 2023.07.05.23292210; doi: https://doi.org/10.1101/2023.07.05.23292210
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area